Comorbid Medical Conditions as Predictors of Overall Survival in Glioblastoma Patients

被引:22
作者
Carr, Matthew T. [1 ]
Hochheimer, Camille J. [2 ]
Rock, Andrew K. [1 ]
Dincer, Alper [1 ]
Ravindra, Lakshmi [1 ]
Zhang, Fan Lily [1 ]
Opalak, Charles F. [1 ]
Poulos, Nora [1 ]
Sima, Adam P. [2 ]
Broaddus, William C. [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23284 USA
[2] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA
关键词
TUMOR VOLUME; RESECTION; EXTENT; TEMOZOLOMIDE; MULTIFORME; GLIOMA; RISK; ANTIHISTAMINE; EPIDEMIOLOGY; RADIOTHERAPY;
D O I
10.1038/s41598-019-56574-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Glioblastoma (GBM) is an aggressive central nervous system tumor with a poor prognosis. This study was conducted to determine any comorbid medical conditions that are associated with survival in GBM. Data were collected from medical records of all patients who presented to VCU Medical Center with GBM between January 2005 and February 2015. Patients who underwent surgery/biopsy were considered for inclusion. Cox proportional hazards regression modeling was performed to assess the relationship between survival and sex, race, and comorbid medical conditions. 163 patients met inclusion criteria. Comorbidities associated with survival on individual-characteristic analysis included: history of asthma (Hazard Ratio [HR]: 2.63; 95% Confidence Interval [CI]: 1.24-5.58; p = 0.01), hypercholesterolemia (HR: 1.95; 95% CI: 1.09-3.50; p = 0.02), and incontinence (HR: 2.29; 95% CI: 0.95-5.57; p = 0.07). History of asthma (HR: 2.22; 95% CI: 1.02-4.83; p = 0.04) and hypercholesterolemia (HR: 1.99; 95% CI: 1.11-3.56; p = 0.02) were associated with shorter survival on multivariable analysis. Surgical patients with GBM who had a prior history of asthma or hypercholesterolemia had significantly higher relative risk for mortality on individual-characteristic and multivariable analyses.
引用
收藏
页数:8
相关论文
共 37 条
[11]   MGMT gene silencing and benefit from temozolomide in glioblastoma [J].
Hegi, ME ;
Diserens, A ;
Gorlia, T ;
Hamou, M ;
de Tribolet, N ;
Weller, M ;
Kros, JM ;
Hainfellner, JA ;
Mason, W ;
Mariani, L ;
Bromberg, JEC ;
Hau, P ;
Mirimanoff, RO ;
Cairncross, JG ;
Janzer, RC ;
Stupp, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :997-1003
[12]   Association Between Tumor Compartment Volumes, the Incidence of Pretreatment Seizures, and Statin-Mediated Protective Effects in Glioblastoma [J].
Henker, Christian ;
Kriesen, Thomas ;
Scherer, Moritz ;
Glass, AEnne ;
von Deimling, Andreas ;
Bendszus, Martin ;
Weber, Marc-Andre ;
Herold-Mende, Christel ;
Unterberg, Andreas ;
Piek, Juergen .
NEUROSURGERY, 2019, 85 (04) :E722-E729
[13]   Glioblastoma care in the elderly [J].
Jordan, Justin T. ;
Gerstner, Elizabeth R. ;
Batchelor, Tracy T. ;
Cahill, Daniel P. ;
Plotkin, Scott R. .
CANCER, 2016, 122 (02) :189-197
[14]   A practical review of prognostic correlations of molecular biomarkers in glioblastoma [J].
Karsy, Michael ;
Neil, Jayson A. ;
Guan, Jian ;
Mark, Mahan A. ;
Colman, Howard ;
Jensen, Randy L. .
NEUROSURGICAL FOCUS, 2015, 38 (03)
[15]   Improved survival time trends for glioblastoma using the SEER 17 population-based registries [J].
Koshy, Matthew ;
Villano, John L. ;
Dolecek, Therese A. ;
Howard, Andrew ;
Mahmood, Usama ;
Chmura, Steven J. ;
Weichselbaum, Ralph R. ;
McCarthy, Bridget J. .
JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (01) :207-212
[16]   Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review [J].
Kubben, Pieter L. ;
ter Meulen, Karlien J. ;
Schijns, Olaf E. M. G. ;
ter Laak-Poort, Mariel P. ;
van Overbeeke, Jacobus J. ;
van Santbrink, Henk .
LANCET ONCOLOGY, 2011, 12 (11) :1062-1070
[17]   Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance [J].
Kuhnt, Daniela ;
Becker, Andreas ;
Ganslandt, Oliver ;
Bauer, Miriam ;
Buchfelder, Michael ;
Nimsky, Christopher .
NEURO-ONCOLOGY, 2011, 13 (12) :1339-1348
[18]   Allergy may confer better survival on patients with gliomas [J].
Lehrer, Steven ;
Rheinstein, Peter H. ;
Rosenzweig, Kenneth E. .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2019, 177 :63-67
[19]   ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma [J].
Li, Guanzhang ;
Li, Yiming ;
Liu, Xing ;
Wang, Zheng ;
Zhang, Chuanbao ;
Wu, Fan ;
Jiang, Haoyu ;
Zhang, Wenlong ;
Bao, Zhaoshi ;
Wang, Yongzhi ;
Cai, Jinquan ;
Zhao, Liang ;
Kahlert, Ulf D. ;
Jiang, Tao ;
Zhang, Wei .
CELL DEATH & DISEASE, 2018, 9
[20]   Current state of immunotherapy for glioblastoma [J].
Lim, Michael ;
Xia, Yuanxuan ;
Bettegowda, Chetan ;
Weller, Michael .
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (07) :422-442